← Back to Search

Sympathomimetic Agent and Anticholinergic Agent

0 Drop for ROP

N/A
Waitlist Available
Led By Monisha Bahri, MD
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Premature infants undergoing clinically indicated retinal exams
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Approved for 5 Other Conditions
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

The purpose of this study is to compare the dilating effect of 0, 1, 2 or 3 drops of mydriatic (pupil dilating) in premature infants undergoing routine retinal (eye) screening exams for Retinopathy of Prematurity (ROP).

Eligible Conditions
  • ROP

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: 2 dropExperimental Treatment1 Intervention
Left eye dose
Group II: 1 DropExperimental Treatment1 Intervention
Left eye dose
Group III: 0 DropExperimental Treatment1 Intervention
Left eye dose
Group IV: 3 dropsActive Control1 Intervention
Right eye dose for all groups
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cyclopentolate
FDA approved

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
350 Previous Clinical Trials
139,149 Total Patients Enrolled
Monisha Bahri, MDPrincipal InvestigatorGeorgetown University Hospital
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top